Strs Ohio Vertex Pharmaceuticals Inc Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Strs Ohio holds 89,709 shares of VRTX stock, worth $42.5 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

89,709

Previous 92,938 3.47%

Holding current value

$42.5 Million

Previous $38.8 Million 8.23%

% of portfolio

0.17%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$392.81 - $485.53 $1.27 Million - $1.57 Million	-3,229 Reduced 3.47%	89,709 $42 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $2.04 Million - $2.24 Million	-5,015 Reduced 5.12%	92,938 $38.8 Million
Q4 2023 Jan 30, 2024	SELL	$343.0 - $410.68 $1.43 Million - $1.71 Million	-4,161 Reduced 4.07%	97,953 $39.9 Million
Q3 2023 Oct 26, 2023	SELL	$338.18 - $362.46 $1.02 Million - $1.09 Million	-3,011 Reduced 2.86%	102,114 $35.5 Million
Q2 2023 Jul 31, 2023	SELL	$314.42 - $351.91 $1.37 Million - $1.53 Million	-4,344 Reduced 3.97%	105,125 $37 Million
Q1 2023 Aug 02, 2023	BUY	$283.23 - $323.1 $1.23 Million - $1.4 Million	4,344 Added 4.13%	109,469 $34.5 Million
Q1 2023 Apr 27, 2023	BUY	$283.23 - $323.1 $37,103 - $42,326	131 Added 0.12%	109,469 $34.5 Million
Q4 2022 Jan 26, 2023	SELL	$285.76 - $321.48 $1.82 Million - $2.04 Million	-6,357 Reduced 5.49%	109,338 $31.6 Million
Q3 2022 Oct 27, 2022	SELL	$273.83 - $305.53 $160,464 - $179,040	-586 Reduced 0.5%	115,695 $33.5 Million
Q2 2022 Jul 25, 2022	SELL	$234.96 - $292.55 $318,840 - $396,990	-1,357 Reduced 1.15%	116,281 $32.8 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $1.82 Million - $2.14 Million	8,207 Added 7.5%	117,638 $30.7 Million
Q4 2021 Jan 24, 2022	SELL	$177.01 - $223.45 $475,802 - $600,633	-2,688 Reduced 2.4%	109,431 $24 Million
Q3 2021 Oct 22, 2021	SELL	$181.39 - $202.99 $1.35 Million - $1.51 Million	-7,461 Reduced 6.24%	112,119 $20.3 Million
Q2 2021 Jul 26, 2021	SELL	$187.49 - $221.1 $104,806 - $123,594	-559 Reduced 0.47%	119,580 $24.1 Million
Q1 2021 Apr 23, 2021	SELL	$207.02 - $241.31 $2.1 Million - $2.45 Million	-10,159 Reduced 7.8%	120,139 $25.8 Million
Q4 2020 Jan 25, 2021	SELL	$207.01 - $276.09 $31.7 Million - $42.3 Million	-153,194 Reduced 54.04%	130,298 $30.8 Million
Q3 2020 Dec 14, 2020	SELL	$255.65 - $303.1 $7.73 Million - $9.16 Million	-30,232 Reduced 9.64%	283,492 $77.1 Million
Q2 2020 Jul 23, 2020	SELL	$225.48 - $295.8 $2.63 Million - $3.46 Million	-11,685 Reduced 3.59%	313,724 $91.1 Million
Q1 2020 Apr 23, 2020	SELL	$199.77 - $247.81 $1.45 Million - $1.8 Million	-7,266 Reduced 2.18%	325,409 $77.4 Million
Q4 2019 Jan 24, 2020	SELL	$166.71 - $223.91 $1.21 Million - $1.62 Million	-7,246 Reduced 2.13%	332,675 $72.8 Million
Q3 2019 Oct 21, 2019	SELL	$166.23 - $187.09 $340,106 - $382,786	-2,046 Reduced 0.6%	339,921 $57.6 Million
Q2 2019 Jul 25, 2019	BUY	$164.61 - $190.37 $46,749 - $54,065	284 Added 0.08%	341,967 $62.7 Million
Q1 2019 Apr 19, 2019	BUY	$163.73 - $194.7 $94,635 - $112,536	578 Added 0.17%	341,683 $62.9 Million
Q4 2018 Jan 23, 2019	BUY	$151.91 - $192.21 $160,416 - $202,973	1,056 Added 0.31%	341,105 $56.5 Million
Q3 2018 Oct 19, 2018	SELL	$167.73 - $192.74 $5.4 Million - $6.2 Million	-32,193 Reduced 8.65%	340,049 $65.5 Million
Q2 2018 Aug 06, 2018	SELL	$145.72 - $169.96 $1.45 Million - $1.69 Million	-9,929 Reduced 2.6%	372,242 $63.3 Million
Q1 2018 Apr 20, 2018	SELL	$151.6 - $177.13 $1.46 Million - $1.71 Million	-9,650 Reduced 2.46%	382,171 $62.3 Million
Q4 2017 Jan 23, 2018	BUY	$137.28 - $155.55 $1.82 Million - $2.06 Million	13,232 Added 3.5%	391,821 $58.7 Million
Q3 2017 Oct 23, 2017	BUY	$148.13 - $162.24 $56.1 Million - $61.4 Million	378,589	378,589 $57.6 Million

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account